Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ONC | Toronto | CAD | Real-time | |
ONCY | NASDAQ | USD | Real-time | |
ONC | CBOE Canada | CAD | Real-time |
For the three months ended 31 March 2022, Oncolytics Biotech Inc revenues was not reported. Net loss increased 5% to C$6.8M. Higher net loss reflects Foreign exchange loss increase of 21% to C$474K (expense), Depreciation - property and equipment increase of 17% to C$24K (expense), Interest income, net decrease of 13% to C$19K (income). Basic Earnings per Share excluding Extraordinary Items increased from -C$0.13 to -C$0.12.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -6.31 | -7.45 | -6.16 | -6.72 |
Net Income | -6.78 | -7.75 | -4.87 | -7.25 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 44.45 | 45.88 | 52.59 | 56.31 |
Total Liabilities | 9.43 | 9.78 | 9.88 | 9.82 |
Total Equity | 35.02 | 36.1 | 42.71 | 46.49 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -6.25 | -22.43 | -16.1 | -12.37 |
Cash From Investing Activities | -0.04 | -0.29 | -0.21 | -0.01 |
Cash From Financing Activities | 5.01 | 33.02 | 33.07 | 33.15 |
Net Change in Cash | -1.78 | 10.04 | 16.87 | 19.58 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review